Semax 5 mg

Peptide Hubs Selank

Peptide Hubs offers premium, lab-tested Selank 10 mg, a synthetic heptapeptide originally developed from the endogenous immunomodulator tuftsin. This advanced nootropic and anxiolytic compound is engineered for research into cognitive enhancement, stress resilience, and emotional regulation without sedation. Sourced from a legit Peptide Hubs network and verified by independent laboratory analysis, this lyophilized powder provides researchers with a reliable tool to investigate GABA system modulation, neurotrophic factor expression, and the peptide's unique ability to enhance learning and memory while reducing anxiety-like behaviors in experimental models.

Selank Composition

Each 2 mL glass vial contains 10 mg of high-purity Selank (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) in sterile, lyophilized powder form. Recent third-party lab analysis confirmed a potency of 12.72 mg per vial—significantly exceeding the labeled amount—demonstrating our commitment to providing researchers with a high-value compound. The product is synthesized without additives, ensuring precise dosing upon reconstitution for controlled experimental protocols.

Bodybuilding Benefits

For researchers focusing on athletic performance and physique enhancement, Selank presents a compelling subject for studying the mind-body connection under stress. Intense training, dieting, and competition preparation create significant psychological stress that can impair recovery, sleep, and adherence. Research into Selank's anxiolytic properties can explore its potential to mitigate training-induced anxiety and improve stress resilience without cognitive impairment. Furthermore, its nootropic effects on memory and learning may be relevant for studying motor skill acquisition and technique refinement. By potentially modulating the brain's response to physical and psychological stressors, Selank serves as a research tool for optimizing mental performance and recovery—critical but often overlooked components of athletic success.

Therapeutic Indication

In preclinical and clinical research, Selank is primarily investigated for anxiety disorders, depression, and cognitive enhancement. Its multi-mechanism action includes modulation of the GABAergic system, influence on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, and effects on serotonin and dopamine metabolism. Unlike benzodiazepines, Selank appears to reduce anxiety without causing sedation, muscle relaxation, or significant memory impairment. Research published in sources like the PubMed Central (PMC) database highlights its potential for treating generalized anxiety disorder and improving cognitive function. This makes it a valuable compound for neuropsychiatric research and studies on neuroplasticity.

Dosage Men

For Research Purposes Only: The following is based on published research literature for informational context. Actual research dosing must be determined by qualified investigators. In human research studies, typical intranasal doses range from 200 mcg to 750 mcg per day, often divided into 2-3 administrations. For subcutaneous research in animal models, doses are calculated based on body weight (e.g., 50-300 mcg/kg). Researchers must establish appropriate dosing for their specific model, beginning with the lowest possible dose to assess response.

Dosage Women

Existing research does not indicate significant gender-based differences in Selank's effects or dosing. However, studies involving female models must consider hormonal cycles that may influence anxiety-like behaviors and cognitive testing outcomes. All research must follow ethical guidelines with dosing based on the physiological parameters of the model. Institutional oversight is mandatory for all in vivo research.

Active Life & Pharmacokinetics

Selank exhibits a relatively short plasma half-life but demonstrates prolonged behavioral and biochemical effects in research models, suggesting active metabolites or sustained receptor modulation. Its effects on anxiety and cognition in studies often persist beyond the measurable presence of the parent compound in plasma. This pharmacokinetic profile supports once or twice-daily administration protocols in research designs aimed at observing sustained neurobehavioral outcomes.

Selank Side Effects

Research indicates Selank is generally well-tolerated with a favorable safety profile. Reported effects in human studies are minimal and may include very mild, transient dizziness or skin reactions at the administration site in sensitive individuals. Crucially, it does not appear to cause the sedation, cognitive dulling, or dependency associated with traditional anxiolytics. In animal models, no significant adverse effects are typically observed at standard research doses. Its safety profile makes it a suitable candidate for long-term neurobehavioral research protocols.

Selank Contraindications/Precautionary Measures

Research should be conducted with caution in models with severe hypotension or acute renal impairment. Although no direct interactions are well-documented, researchers should be aware of potential additive effects with other CNS depressants. All handling must occur in a sterile laboratory environment. Researchers should consult authoritative resources like the National Institute of Mental Health (NIMH) for background on anxiety and neuropsychiatric research models. Standard laboratory safety protocols for peptide handling apply.

Overdosage

Data on Selank overdose is extremely limited due to its wide therapeutic window and low toxicity. In research settings, significantly exceeding standard experimental doses may lead to exaggerated pharmacological effects such as excessive anxiolysis or, theoretically, hypotension. Such outcomes would compromise both animal welfare and research validity. Researchers must implement dose calculation checks and have emergency supportive protocols in place.

Selank Stack/Cycle for Research Models

Selank is often researched alongside other nootropic or neuroprotective peptides to study synergistic effects on brain function and resilience. For comprehensive cognitive enhancement research, it can be stacked with its analog Semax 5 mg to compare and combine their distinct mechanisms. For studies on stress adaptation and recovery, combinations with adaptogens like Pinealon 20 mg or neuroprotective peptides like Cerebrolysin are of interest. To investigate the intersection of cognitive function and metabolic health in athletes, research might include peptides like GHK-Cu 50 mg for its tissue repair and anti-inflammatory properties. For sleep and recovery studies, combining with DSIP 10 mg could explore integrated stress-sleep-cognition axes. Such stacks require sophisticated, controlled experimental designs.

Package Presentation

Each order unit consists of one sealed, tamper-evident 2 mL glass vial containing 10 mg of Selank as a white lyophilized powder. The vial is clearly labeled with the product name, batch number, expiration date, and net weight for full traceability.

Storage

For optimal long-term stability, store unopened vials refrigerated at 2-8°C (36-46°F). Protect from light and moisture. After reconstitution with bacteriostatic water or sterile saline, the solution should be refrigerated and used within the timeframe dictated by your laboratory's sterility standards—typically within 7-10 days when handled with proper aseptic technique.

Selank Referrers

Selank represents an innovative approach to psychopharmacology, demonstrating that peptides can achieve significant neurobehavioral effects with minimal side effects. Its development from tuftsin highlights how modifying endogenous peptide structures can create compounds with targeted, beneficial activities. As a research tool, Peptide Hubs' verified Selank enables scientists to explore novel pathways for managing anxiety and enhancing cognitive performance, contributing to the growing field of peptide-based neuroscience and the search for non-addictive, performance-preserving anxiolytics.

Third-Party Lab Tests

Transparency is paramount. Our Selank 10 mg is subjected to independent verification. Below are recent lab test results confirming the purity and superior potency of our product.

2026-01-12

View Result

12.72 mg

2025-04-22

View Result

9.69 mg